Consistent with our results, Tondini et al. and Tian et al. evaluated CD4+ T and CD8+ T cells in vivo by injecting anti-CD4 and anti-CD8 antibodies in mice, and found that tumor regression was dependent on CD4+ T and CD8+ T cells [25,26,27]. The gene discussed is CD8A; the disease is neoplasm.